Tag: biosimilar coding
Biosimilars are billed differently than generics under Medicare Part B. Each has its own HCPCS code and payment rate based on its ASP plus 6% of the reference product’s price. This system encourages biosimilar entry but doesn’t strongly incentivize switching. Learn how billing works and why adoption remains low in the U.S.
Medications
Archives
Recent-posts
Generic vs Brand-Name Drugs: Key Differences Explained
Jan, 30 2026
Opioids During Pregnancy: Risks, Withdrawal, and Monitoring
Jan, 1 2026
Best Digital Tools for Patient Education: Apps and E-Learning in 2025
Dec, 27 2025
Top Subscription Telehealth Services in 2025: Membership Models for Online Healthcare
Apr, 26 2025
Continuing Education for Doctors: Staying Current on Generic Medications
Mar, 16 2026